Business
FMC Corporation sets 2026 priorities and announces exploration of strategic options including but not limited to the sale of the company
FMC Corporation (NYSE: FMC) today announced its 2026 priorities and the authorization by the Board to explore strategic options. The company also reported fourth quarter and full year 2025 results and provided its 2026 outlook.
About this update from Fmc Corporation
[{"type":"text","content":"Company reports 2025 fourth quarter and full year results, provides 2026 outlook ","length":80,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"The organization continues to focus on its 2026 operational priorities, including strengthening the balance sheet, improving the competitiveness of its core portfolio, managing its post-patent Rynaxypyr® active strategy and supporting growth of new active ingredients","length":267,"tagName":"p"}]},{"val":[{"type":"text","content":"The FMC Board of Directors has authorized the exploration of strategic options, including but not limited to, the sale of the company to unlock shareholder value and ensure its growth and core portfolios are best positioned for long-term success","length":245,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":512,"olType":false},{"type":"image","alt":"FMC Corporation Logo. (PRNewsFoto/FMC Corporation)","displaySize":"","headline":null,"caption":"FMC Corporation Logo. (PRNewsFoto/FMC Corporation)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":151,"url":"https://media.zenfs.com/en/prnewswire.com/c63bdd06a18e763f64f52e9558b8a11a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6IHmOXvTcOa46GCIKibY4g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI2NjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/c63bdd06a18e763f64f52e9558b8a11a","width":400,"height":151}},"href":"https://mma.prnewswire.com/media/331912/fmc_corporation_logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"PHILADELPHIA, Feb. 4, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced its 2026 priorities and the authorization by the Board to explore strategic options. The company also reported fourth quarter and full year 2025 results and provided its 2026 outlook.","length":280,"tagName":"p"},{"type":"text","content":"FMC is focused on executing its 2026 operational priorities, one of which is strengthening the balance sheet by paying down $1 billion in debt through asset sales and licensing agreements. This includes the previously announced sale of the India commercial business. Further priorities focus on improving the competitiveness of the company's legacy core portfolio and managing the post-patent transition for Rynaxypyr® active. FMC will also continue advancing commerciali...